Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT06739278 Sponsor: Second Affiliated Hospital of Wenzhou Medical University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT06739278
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with a type of Crohn's disease that causes tunnels or passages to form in the skin around the back passage (perianal fistulizing Crohn's disease).
  • People who are receiving a medication called ustekinumab as part of their treatment.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are taking ustekinumab alongside hormones, immunosuppressants (medicines that reduce the immune system's activity), other biologic medicines, or certain small targeted drugs.
  • People who also have another autoimmune condition, such as lupus, rheumatoid arthritis, or Graves' disease (a thyroid condition), among others.
  • People who also have a serious active infection, such as active tuberculosis, Epstein-Barr virus (EBV) infection, or cytomegalovirus infection, among others.
  • People who have been diagnosed with a malignant (cancerous) tumour.
  • People whose medical records have more than 30% of important data missing, or for whom there is no follow-up information available.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-13676715543

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Registry
ClinicalTrials.gov
Start date
20 December 2024
Est. completion
31 December 2024

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

imaging remission rate of anal fistula

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov